Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,008,850
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000652
- Form type
- SC 13G
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Sep 21, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership